3 of the very best ASX shares to buy now

These shares are highly rated by the team at Bell Potter for a reason.

| More on:
Happy shareholders clap and smile as they listen to a company earnings report.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With markets still struggling for direction, now might be the ideal time for long-term investors to focus on quality — and there's no shortage of it on the ASX.

Analysts at Bell Potter have recently named a select group of ASX shares they believe represent the very best opportunities on the market right now.

Here are three of Bell Potter's top-rated shares to buy now — and why they're backed to outperform.

James Hardie Industries plc (ASX: JHX)

The first ASX share that could be a best buy according to Bell Potter is James Hardie. It is the dominant player in fibre cement and internal lining solutions — and it is particularly well positioned in the U.S. residential market, where a structural shift is taking place away from timber and vinyl towards more durable and lower-maintenance options like fibre cement.

Bell Potter believes this macro trend is set to continue, giving James Hardie a powerful multi-year tailwind. Following a recent pullback in the share price, the broker sees a compelling buying opportunity. It commented:

In our view, JHX is poised for continued earnings expansion, driven by the structural shift towards fibre cement in the US. Households in the US continue to shift to fibre cement cladding from vinyl/timber, providing a multi-year runway for JHX's revenue and profit growth.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix is quickly establishing itself as one of the most promising ASX healthcare shares. The company has successfully commercialised Illuccix, a prostate cancer imaging agent, and has multiple product launches and clinical trial readouts expected over the next two years.

The broker sees Telix as uniquely positioned in the growing field of radiopharmaceuticals, where demand for precision diagnostics and targeted therapies is accelerating. It also points to Telix's strong earnings growth outlook and attractive valuation. It said:

Valuations are attractive, with 12MF P/E now at 41x, supported by a 2yr EPS CAGR of 44%.

WiseTech Global Ltd (ASX: WTC)

A third ASX share that could be a best buy is WiseTech Global. It is the dominant force in global freight forwarding software. Its flagship CargoWise platform is mission-critical for some of the world's biggest logistics players, offering integration, automation, and efficiency at scale.

Bell Potter sees ongoing growth through both organic expansion and strategic acquisitions, with the company set to benefit from global supply chain digitisation and further product rollouts. The broker said:

WTC is a growth story with strategic acquisitions representing upside potential enabling WTC to benefit from large-scale global rollouts and consolidation within the logistics sector.

Motley Fool contributor James Mickleboro has positions in WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

Buy, hold, sell: Amcor, ANZ, and Macquarie shares

Does a leading broker think investors should be buying these blue chips? Let's find out.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »

A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Aristocrat, James Hardie, and TechnologyOne shares

Morgans has given its verdict on these popular shares. Is it bullish, bearish, or something in between?

Read more »

A satisfied business woman with three fluggly pink clouds in the shape of a heart
Broker Notes

9 ASX All Ords shares upgraded to strong buy ratings for the new year

Seeking investment inspiration for the new year? Here are the latest consensus tips.

Read more »

Man presses green buy button and red sell button on a graph.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Broker Notes

2 ASX shares experts think will smash the market in 2026!

Big returns could be on the cards for investors with these shares according to analysts.

Read more »